The use of novel waveforms, frequencies, and stimulation modes in spinal cord stimulation (SCS) therapies may be more effective at relieving chronic low back pain and/or leg pain compared with traditional tonic low-frequency SCS.
Daily use of a high-frequency transcutaneous electrical nerve stimulation device may reduce pain and improve function in patients with chronic low back pain.
Dorsal root ganglion stimulation for chronic pain may be associated with paresthesia with reduced coverage area, intensity, and frequency compared with tonic spinal cord stimulation.
A 1-hour treatment with external trigeminal nerve stimulation was found to alleviate pain in individuals with migraine without aura.
Peripheral nerve stimulation at 10 KHz was found to be efficacious in reducing chronic pain.
Bayer announced the launch of Aleve Direct Therapy, a pain relief device.
